The Role of Palmitoleic Acid in Regulating Hepatic Gluconeogenesis through SIRT3 in Obese Mice
Xin Guo, Xiaofan Jiang, Keyun Chen, Qijian Liang, Shixiu Zhang, Juan Zheng, Xiaomin Ma, Hongmei Jiang, Hao Wu, Qiang Tong, Xin Guo, Xiaofan Jiang, Keyun Chen, Qijian Liang, Shixiu Zhang, Juan Zheng, Xiaomin Ma, Hongmei Jiang, Hao Wu, Qiang Tong
Abstract
Hepatic gluconeogenesis is a crucial process to maintain glucose level during starvation. However, unabated glucose production in diabetic patients is a major contributor to hyperglycemia. Palmitoleic acid is a monounsaturated fatty acid (16:1n7) that is available from dietary sources. Palmitoleic acid exhibits health beneficial effects on diabetes, insulin resistance, inflammation, and metabolic syndrome. However, the mechanism by which palmitoleate reduces blood glucose is still unclear. SIRT3 is a key metabolism-regulating NAD+-dependent protein deacetylase. It is known that fasting elevates the expression of SIRT3 in the liver and it regulates many aspects of liver's response to nutrient deprivation, such as fatty acid oxidation and ketone body formation. However, it is unknown whether SIRT3 also regulates gluconeogenesis. Our study revealed that palmitoleic acid reduced hepatic gluconeogenesis and the expression of SIRT3 under high-fat diet conditions. Overexpression of SIRT3 in the liver and hepatocytes enhanced gluconeogenesis. Further study revealed that SIRT3 played a role in enhancing the activities of gluconeogenic enzymes, such as PEPCK, PC, and MDH2. Therefore, our study indicated that under a high-fat diet, palmitoleic acid decreased gluconeogenesis by reducing enzymatic activities of PEPCK, PC, and MDH2 by down-regulating the expression of SIRT3.
Keywords: SIRT3; gluconeogenesis; high-fat diet; palmitoleic acid.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
- Naghavi M., Wang H., Lozano R., Davis A., Liang X., Zhou M., Vollset S.E., Ozgoren A.A., Abdalla S., Abd-Allah F., et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–171. doi: 10.1016/s0140-6736(14)61682-2.
- Jia G., DeMarco V.G., Sowers J.R. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat. Rev. Endocrinol. 2016;12:144–153. doi: 10.1038/nrendo.2015.216.
- Roden M., Shulman G.I. The integrative biology of type 2 diabetes. Nature. 2019;576:51–60. doi: 10.1038/s41586-019-1797-8.
- Hu W., Fitzgerald M., Topp B., Alam M., O’Hare T.J. A review of biological functions, health benefits, and possible de novo biosynthetic pathway of palmitoleic acid in macadamia nuts. J. Funct. Foods. 2019;62:103520. doi: 10.1016/j.jff.2019.103520.
- Astudillo A.M., Meana C., Guijas C., Pereira L., Lebrero P., Balboa M.A., Balsinde J. Occurrence and biological activity of palmitoleic acid isomers in phagocytic cells. J. Lipid Res. 2018;59:237–249. doi: 10.1194/jlr.M079145.
- Bueno-Hernandez N., Sixtos-Alonso M.S., del Pilar MilKe M., Yamamoto-Furusho J.K. Effect of Cis-palmitoleic acid supplementation on inflammation and expression of HNF4 gamma, HNF4 alpha and IL6 in patients with ulcerative colitis. Minerva Gastroenterol. E Dietol. 2017;63:257–263. doi: 10.23736/s1121-421x.17.02367-4.
- Talbot N.A., Wheeler-Jones C.P., Cleasby M.E. Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated-skeletal muscle insulin resistance. Mol. Cell. Endocrinol. 2014;393:129–142. doi: 10.1016/j.mce.2014.06.010.
- Guo X., Li H., Xu H., Halim V., Zhang W., Wang H., Ong K.T., Woo S.-L., Walzem R.L., Mashek D.G., et al. Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice. PLoS ONE. 2012;7:e39286. doi: 10.1371/journal.pone.0039286.
- Bolsoni-Lopes A., Festuccia W.T., Chimin P., Farias T.S.M., Torres-Leal F.L., Cruz M.M., Andrade P.B., Hirabara S.M., Lima F.B., Alonso-Vale M.I.C. Palmitoleic acid (n-7) increases white adipocytes GLUT4 content and glucose uptake in association with AMPK activation. Lipids Health Dis. 2014;13:199. doi: 10.1186/1476-511X-13-199.
- Verdin E. NAD(+) in aging, metabolism, and neurodegeneration. Science. 2015;350:1208–1213. doi: 10.1126/science.aac4854.
- Shi T., Wang F., Stieren E., Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 2005;280:13560–13567. doi: 10.1074/jbc.M414670200.
- Lin L., Chen K., Khalek W.A., Ward J.L., III, Yang H., Chabi B., Wrutniak-Cabello C., Tong Q. Regulation of Skeletal Muscle Oxidative Capacity and Muscle Mass by SIRT3. PLoS ONE. 2014;9:e85636. doi: 10.1371/journal.pone.0085636.
- Sundaresan N.R., Gupta M., Kim G., Rajamohan S.B., Isbatan A., Gupta M.P. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Investig. 2009;119:2758–2771. doi: 10.1172/JCI39162.
- Ma Y., Chai H., Ding Q., Qian Q., Yan Z., Ding B., Dou X., Li S. Hepatic SIRT3 Upregulation in Response to Chronic Alcohol Consumption Contributes to Alcoholic Liver Disease in Mice. Front. Physiol. 2019;10:1042. doi: 10.3389/fphys.2019.01042.
- Lombard D.B., Zwaans B.M.M. SIRT3: As Simple As It Seems? Gerontology. 2014;60:56–64. doi: 10.1159/000354382.
- Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., Grueter C.A., Harris C., Biddinger S., Ilkayeva O.R., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010;464:121–125. doi: 10.1038/nature08778.
- Shimazu T., Hirschey M.D., Hua L., Dittenhafer-Reed K.E., Schwer B., Lombard D.B., Li Y., Bunkenborg J., Alt F.W., Denu J.M., et al. SIRT3 Deacetylates Mitochondrial 3-Hydroxy-3-Methylglutaryl CoA Synthase 2 and Regulates Ketone Body Production. Cell Metab. 2010;12:654–661. doi: 10.1016/j.cmet.2010.11.003.
- Liu L., Nam M., Fan W., Akie T.E., Hoaglin D.C., Gao G., Keaney J.F., Jr., Cooper M.P. Nutrient sensing by the mitochondrial transcription machinery dictates oxidative phosphorylation. J. Clin. Investig. 2014;124:768–784. doi: 10.1172/JCI69413.
- Jing E., O’Neill B.T., Rardin M.J., Kleinridders A., Ilkeyeva O.R., Ussar S., Bain J.R., Lee K.Y., Verdin E.M., Newgard C.B., et al. Sirt3 Regulates Metabolic Flexibility of Skeletal Muscle Through Reversible Enzymatic Deacetylation. Diabetes. 2013;62:3404–3417. doi: 10.2337/db12-1650.
- Li M., Li C.-M., Ye Z.-C., Huang J., Li Y., Lai W., Peng H., Lou T.-Q. Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice. J. Cell. Mol. Med. 2020;24:5109–5121. doi: 10.1111/jcmm.15148.
- Ye X., Li M., Hou T., Gao T., Zhu W.-g., Yang Y. Sirtuins in glucose and lipid metabolism. Oncotarget. 2017;8:1845–1859. doi: 10.18632/oncotarget.12157.
- Cheung K.G., Cole L.K., Xiang B., Chen K., Ma X., Myal Y., Hatch G.M., Tong Q., Dolinsky V.W. Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes. J. Biol. Chem. 2015;290:10981–10993. doi: 10.1074/jbc.M114.607960.
- Jiang X., Zhang Y., Hu W., Liang Y., Zheng L., Zheng J., Wang B., Guo X. Different Effects of Leucine Supplementation and/or Exercise on Systemic Insulin Sensitivity in Mice. Front. Endocrinol. 2021;12:651303. doi: 10.3389/fendo.2021.651303.
- Guo X., Zhu B., Xu H., Li H., Jiang B., Wang Y., Zheng B., Glaser S., Alpini G., Wu C. Adoptive transfer of Pfkfb3-disrupted hematopoietic cells to wild-type mice exacerbates diet-induced hepatic steatosis and inflammation. Liver Res. 2020;4:136–144. doi: 10.1016/j.livres.2020.08.004.
- Zhu B., Guo X., Xu H., Jiang B., Li H., Wang Y., Yin Q., Zhou T., Cai J.J., Glaser S., et al. Adipose tissue inflammation and systemic insulin resistance in mice with diet-induced obesity is possibly associated with disruption of PFKFB3 in hematopoietic cells. Lab. Investig. 2021;101:328–340. doi: 10.1038/s41374-020-00523-z.
- Guo X., Shu C., Li H., Pei Y., Woo S.-L., Zheng J., Liu M., Xu H., Botchlett R., Guo T., et al. Cyclic GMP-AMP Ameliorates Diet-induced Metabolic Dysregulation and Regulates Proinflammatory Responses Distinctly from STING Activation. Sci. Rep. 2017;7:6355. doi: 10.1038/s41598-017-05884-y.
- Ferchaud-Roucher V., Barner K., Jansson T., Powell T.L. Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties. FASEB J. 2019;33:6643–6654. doi: 10.1096/fj.201802444R.
- Frigolet M.E., Gutierrez-Aguilar R. The Role of the Novel Lipokine Palmitoleic Acid in Health and Disease. Adv. Nutr. 2017;8:173S–181S. doi: 10.3945/an.115.011130.
- Liu Y., Shen X., Pang M., Sun Z., Qian Y., Xue W., Wang Z., Li L. Role of histone deacetylase Sirt3 in the development and regression of atherosclerosis. Life Sci. 2021;272:119178. doi: 10.1016/j.lfs.2021.119178.
- Giralt A., Villarroya F. SIRT3, a pivotal actor in mitochondrial functions: Metabolism, cell death and aging. Biochem. J. 2012;444:1–10. doi: 10.1042/BJ20120030.
- Nakamura A., Kawakami K., Kametani F., Goto S. Dietary Restriction Increases Protein Acetylation in the Livers of Aged Rats. Gerontology. 2013;59:542–548. doi: 10.1159/000354087.
- Hebert A.S., Dittenhafer-Reed K.E., Yu W., Bailey D.J., Selen E.S., Boersma M.D., Carson J.J., Tonelli M., Balloon A.J., Higbee A.J., et al. Calorie Restriction and SIRT3 Trigger Global Reprogramming of the Mitochondrial Protein Acetylome. Mol. Cell. 2013;49:186–199. doi: 10.1016/j.molcel.2012.10.024.
- Arima Y., Nakagawa Y., Takeo T., Ishida T., Yamada T., Hino S., Nakao M., Hanada S., Umemoto T., Suda T., et al. Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation. Nat. Metab. 2021;3:196–210. doi: 10.1038/s42255-021-00342-6.
- Nie Y.Z., Erion D.M., Yuan Z.L., Dietrich M., Shulman G.I., Horvath T.L., Gao Q. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat. Cell Biol. 2009;11:492–500. doi: 10.1038/ncb1857.
- Petersen M.C., Vatner D.F., Shulman G.I. Regulation of hepatic glucose metabolism in health and disease. Nat. Rev. Endocrinol. 2017;13:572–587. doi: 10.1038/nrendo.2017.80.
- Rui L. Energy Metabolism in the Liver. Compr. Physiol. 2014;4:177–197. doi: 10.1002/cphy.c130024.
- Narita T., Weinert B.T., Choudhary C. Functions and mechanisms of non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 2019;20:156–174. doi: 10.1038/s41580-018-0081-3.
- De Wit N., Derrien M., Bosch-Vermeulen H., Oosterink E., Keshtkar S., Duval C., de Vogel-van den Bosch J., Kleerebezem M., Muller M., van der Meer R. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am. J. Physiol.-Gastrointest. Liver Physiol. 2012;303:G589–G599. doi: 10.1152/ajpgi.00488.2011.
- Buettner R., Parhofer K.G., Woenckhaus M., Wrede C.E., Kunz-Schughart L.A., Schoelmerich J., Bollheimer L.C. Defining high-fat-diet rat models: Metabolic and molecular effects of different fat types. J. Mol. Endocrinol. 2006;36:485–501. doi: 10.1677/jme.1.01909.
- Zbikowski A., Blachnio-Zabielska A., Galli M., Zabielski P. Adipose-Derived Exosomes as Possible Players in the Development of Insulin Resistance. Int. J. Mol. Sci. 2021;22:7427. doi: 10.3390/ijms22147427.
- Al-Mansoori L., Al-Jaber H., Prince M.S., Elrayess M.A. Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance. Inflammation. 2022;45:31–44. doi: 10.1007/s10753-021-01559-z.
- Nunes E.A., Rafacho A. Implications of Palmitoleic Acid (Palmitoleate) On Glucose Homeostasis, Insulin Resistance and Diabetes. Curr. Drug Targets. 2017;18:619–628. doi: 10.2174/1389450117666151209120345.
- Souza C.O., Teixeira A.A.S., Lima E.A., Batatinha H.A.P., Gomes L.M., Carvalho-Silva M., Mota I.T., Streck E.L., Hirabara S.M., Rosa Neto J.C. Palmitoleic Acid (N-7) Attenuates the Immunometabolic Disturbances Caused by a High-Fat Diet Independently of PPAR alpha. Mediat. Inflamm. 2014;2014:582197. doi: 10.1155/2014/582197.
- Cao H.M., Gerhold K., Mayers J.R., Wiest M.M., Watkins S.M., Hotamisligil G.S. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell. 2008;134:933–944. doi: 10.1016/j.cell.2008.07.048.
- Pinnick K.E., Neville M.J., Fielding B.A., Frayn K.N., Karpe F., Hodson L. Gluteofemoral Adipose Tissue Plays a Major Role in Production of the Lipokine Palmitoleate in Humans. Diabetes. 2012;61:1399–1403. doi: 10.2337/db11-1810.
- Stefan N., Kantartzis K., Celebi N., Staiger H., Machann J., Schick F., Cegan A., Elcnerova M., Schleicher E., Fritsche A., et al. Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans. Diabetes Care. 2010;33:405–407. doi: 10.2337/dc09-0544.
- De Souza C.O., Vannice G.K., Rosa Neto J.C., Calder P.C. Is Palmitoleic Acid a Plausible Nonpharmacological Strategy to Prevent or Control Chronic Metabolic and Inflammatory Disorders? Mol. Nutr. Food Res. 2018;62:1700504. doi: 10.1002/mnfr.201700504.
- Campbell J.E., Newgard C.B. Mechanisms controlling pancreatic islet cell function in insulin secretion. Nat. Rev. Mol. Cell Biol. 2021;22:142–158. doi: 10.1038/s41580-020-00317-7.
- Hutfles L.J., Wilkins H.M., Koppel S.J., Weidling I.W., Selfridge J.E., Tan E., Thyfault J.P., Slawson C., Fenton A.W., Zhu H., et al. A bioenergetics systems evaluation of ketogenic diet liver effects. Appl. Physiol. Nutr. Metab. 2017;42:955–962. doi: 10.1139/apnm-2017-0068.
- Wang Q., Zhang Y., Yang C., Xiong H., Lin Y., Yao J., Li H., Xie L., Zhao W., Yao Y., et al. Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux. Science. 2010;327:1004–1007. doi: 10.1126/science.1179687.
- Yang H., Zhou L., Shi Q., Zhao Y., Lin H., Zhang M., Zhao S., Yang Y., Ling Z.-Q., Guan K.-L., et al. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth. EMBO J. 2015;34:1110–1125. doi: 10.15252/embj.201591041.
- Burgess S.C., He T., Yan Z., Lindner J., Sherry A.D., Malloy C.R., Browning J.D., Magnuson M.A. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab. 2007;5:313–320. doi: 10.1016/j.cmet.2007.03.004.
- Jiang W., Wang S., Xiao M., Lin Y., Zhou L., Lei Q., Xiong Y., Guan K.-L., Zhao S. Acetylation Regulates Gluconeogenesis by Promoting PEPCK1 Degradation via Recruiting the UBR5 Ubiquitin Ligase. Mol. Cell. 2011;43:33–44. doi: 10.1016/j.molcel.2011.04.028.
- Latorre-Muro P., Baeza J., Armstrong E.A., Hurtado-Guerrero R., Corzana F., Wu L.E., Sinclair D.A., Lopez-Buesa P., Carrodeguas J.A., Denu J.M. Dynamic Acetylation of Phosphoenolpyruvate Carboxykinase Toggles Enzyme Activity between Gluconeogenic and Anaplerotic Reactions. Mol. Cell. 2018;71:718–732. doi: 10.1016/j.molcel.2018.07.031.
Source: PubMed